Citation Impact
2 from Science/Nature 66 standout
Citing Papers
Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer
2023 Standout
Pan-cancer efficacy of pralsetinib in patients with RET fusion–positive solid tumors from the phase 1/2 ARROW trial
2022 Standout
Works of R Riou being referenced
[Primary bronchial carcinoma in elderly subjects in France].
2003
Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Français de Pneumo-Cancérologie (GFPC) Protocol 95-1
2001
Author Peers
| Author | Oncology | PRM | Epidemiology | Genetics | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| R Riou | 317 | 329 | 61 | 78 | 18 | 415 | |
| Peter T. Stevick | 1 | 37 | 1.5k | ||||
| Ben Ayed H | 29 | 262 | 103 | 20 | 30 | 927 | |
| V. N. Korotchenko | 8 | 1 | 23 | 517 | |||
| Ana R. Brás | 1 | 8 | 37 | 1.3k | |||
| Gitashree Darabdhara | 2 | 3 | 2 | 1 | 27 | 1.7k |
All Works
Loading papers...